EQT Partners has increased its offer from SEK 5.973bn (€575m) to SEK 6.151bn (€602m) for the take-private of Stockholm-based pharmaceutical company Karo Pharma.
Renaud Tourmente will join as partner and be part of Capzanine's executive committee
Hitzinger was undergoing self-administration before the consortium acquired the company
Graftys sells products in 25 countries and plans to penetrate new markets with the funding
US pension has targeted $80m for new private markets commitments through the rest of 2019